Follow
ChromoGenics AB
Nasdaq First North Sweden (Sweden)
ChromoGenics AB develops and produces dynamic glass with controllable optical properties in Sweden and internationally. The company offers ConverLight, an electrochromic glass, which provides UV protection for use in single glass pane and insulating glass unit solutions. This glass is suitable for new construction, reconstruction, and renovation and offers ultraviolet protection that reduces the risk of fading interiors.
Sector:
MATERIALS
>
Basic Materials
Building Materials
Sector:
INDUSTRIALS
>
Building Products
New issue
Price
0.25 SEK
Subscription period
19 Feb - 04 Mar 2020
View Details
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
CHRO
SE0009496268
Nasdaq First North Sweden
Sweden (SE)
Details of share in ChromoGenics AB with ticker CHRO
Status
Active
Order book id
Amount of instruments
402 380 447
Par value
0.2000
Market cap
Currency
SEK
Segment
First North
First trading date
23 Mar 2017
Terms
Type
Price
Pre-money valuation
Time
IPO
8.50 SEK
117.3M SEK
09 Feb - 24 Feb 2017
IPO in ChromoGenics AB
Market
Nasdaq First North Sweden
Subscription period
09 Feb - 24 Feb 2017
Subscription price
8.50 SEK
Price per share
8.50 SEK
Target to raise
117 000 000 SEK
Types
Pre-money valuation
117 300 000 SEK
Subscription block size
Minimum subscription
1 000
Record date
Offer status
Closed
Listing status
Listed
First trading date
23 Mar 2017
Issue terms
Type
Price
Pre-money valuation
Time
New issue
1.75 SEK
40.6M SEK
08 Jan - 22 Jan 2018
Share issue in ChromoGenics AB
Market
Nasdaq First North Sweden
Subscription period
08 Jan - 22 Jan 2018
Subscription price
1.75 SEK
Price per share
1.75 SEK
Target to raise
40 600 000 SEK
Types
Share issue
Pre-money valuation
40 600 000 SEK
Subscription block size
Minimum subscription
1 200
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 1:1. One (1) existing share entitles one (1) unit right. One (1) unit right entitles the holder to subscribe for one (1) unit, consisting of one (1) share and one (1) free subscription option. Each warrant entitles the holder to subscribe for one (1) new share in the Company for SEK 3.50 (exercise price) during the period from January 10, 2020 to January 31, 2020. I
Type
Price
Pre-money valuation
Time
Exercise
10.20 SEK
-
01 May - 31 May 2018
Option exercise terms for CHRO TO1
Market
Nasdaq First North Sweden
Exercise period(s)
01 May - 31 May 2018
Exercise price
10.20 SEK
Status
Closed
Issue terms
Pre-emption 1:4. Four (4) existing warrants entitles the holder to subscribe for one (1) share.
Type
Price
Pre-money valuation
Time
New issue
0.60 SEK
233M SEK
28 Jan - 15 Feb 2019
Share issue in ChromoGenics AB
Market
Nasdaq First North Sweden
Subscription period
28 Jan - 15 Feb 2019
Subscription price
0.60 SEK
Price per share
0.60 SEK
Target to raise
77 700 000 SEK
Types
Share issue
Pre-money valuation
233 000 000 SEK
Subscription block size
Minimum subscription
Record date
24 Jan 2019
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 1:3. Holdings of one (1) share entitle to three (3) subscription rights. One (1) subscription right entitles the holder to subscribe for one (1) new share.
Type
Price
Pre-money valuation
Time
New issue
0.50 SEK
86.38M SEK
25 Jun - 15 Jul 2019
Share issue in ChromoGenics AB
Market
Nasdaq First North Sweden
Subscription period
25 Jun - 15 Jul 2019
Subscription price
0.50 SEK
Price per share
0.50 SEK
Target to raise
86 377 990 SEK
Types
Share issue
Pre-money valuation
86 377 990 SEK
Subscription block size
Minimum subscription
Record date
21 Jun 2019
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 1:1. Holding of one (1) share gives one (1) subscription right. One (1) subscription right entitles the holder to subscribe for one (1) new share.
Type
Price
Pre-money valuation
Time
New issue
0.53 SEK
08 Jul 2019
Share issue in ChromoGenics AB
Market
Nasdaq First North Sweden
Subscription date
08 Jul 2019
Subscription price
Price per share
0.53 SEK
Target to raise
10 000 000 SEK
Types
Share issue
Pre-money valuation
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed to Wilhelm Risberg and Fredrik Lundgren.
Comments for offer & related information
Type
Price
Pre-money valuation
Time
New issue
0.56
11 Sep 2019
Share issue in ChromoGenics AB
Market
Nasdaq First North Sweden
Subscription date
11 Sep 2019
Subscription price
Price per share
0.56
Target to raise
15 470 000
Types
Share issue
Pre-money valuation
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Off-set issue directed to Hörmann-Verwertungen GmbH & Co. KG.
Comments for offer & related information
Type
Price
Pre-money valuation
Time
Exercise
1.74 SEK
-
10 Jan - 31 Jan 2020
Option exercise terms for CHRO TO2
Former ticker
CHRO TO 2
Market
Nasdaq First North Sweden
Exercise period(s)
10 Jan - 31 Jan 2020
Exercise price
1.74 SEK
Status
Closed
Issue terms
Update: Recalculated terms after share issue; One (1) warrant of series TO2 entitles the holder to subscribe for 2.02 new shares in the Company during the period 10 - 31 January 2020 for 1.74 SEK per share.

Update: Recalculated terms after share issue; One (1) warrant of series TO2 entitles the holder to subscribe for 1.62 new shares in the Company during the period 10 - 31 January 2020 for 2.17 SEK per share.

One (1) warrant of series TO2 entitles the holder to subscribe for one (1) new share in the Company during the period 10 - 31 January 2020 for 3.50 SEK per share.
Type
Price
Pre-money valuation
Time
New issue
0.25 SEK
100.6M SEK
19 Feb - 04 Mar 2020
Share issue in ChromoGenics AB
Market
Nasdaq First North Sweden
Subscription period
19 Feb - 04 Mar 2020
Subscription price
0.25 SEK
Price per share
0.25 SEK
Target to raise
100 600 000 SEK
Types
Share issue
Pre-money valuation
100 600 000 SEK
Subscription block size
Minimum subscription
Record date
14 Feb 2020
Offer status
Active
Listing status
Listed
 
Issue terms
Each share held in the Company on the record date of February 14, 2020, will receive one (1) subscription right. One (1) subscription right entitles the owner to subscribe to one (1) new share.
Comments for offer & related information
The company shall issue a maximum of 402 380 447 shares.
The Rights Issue is guaranteed at 75.0 percent of the issue amount, corresponding to approximately SEK 75.4 million, through subscription and guarantee undertakings from existing shareholders and external investors.
Type
Ticker
ISIN
Market
SHARE
CHRO
SE0009496268
Nasdaq First North Sweden
Sweden (SE)
Details of share in ChromoGenics AB with ticker CHRO
Status
Active
Order book id
Amount of instruments
402 380 447
Par value
0.2000
Market cap
Currency
SEK
Segment
First North
First trading date
23 Mar 2017
Terms
Type
Price
Pre-money valuation
Time
IPO
8.50 SEK
117.3M SEK
09 Feb - 24 Feb 2017
IPO in ChromoGenics AB
Market
Nasdaq First North Sweden
Subscription period
09 Feb - 24 Feb 2017
Subscription price
8.50 SEK
Price per share
8.50 SEK
Target to raise
117 000 000 SEK
Types
Pre-money valuation
117 300 000 SEK
Subscription block size
Minimum subscription
1 000
Record date
Offer status
Closed
Listing status
Listed
First trading date
23 Mar 2017
Issue terms
Type
Price
Pre-money valuation
Time
New issue
1.75 SEK
40.6M SEK
08 Jan - 22 Jan 2018
Share issue in ChromoGenics AB
Market
Nasdaq First North Sweden
Subscription period
08 Jan - 22 Jan 2018
Subscription price
1.75 SEK
Price per share
1.75 SEK
Target to raise
40 600 000 SEK
Types
Share issue
Pre-money valuation
40 600 000 SEK
Subscription block size
Minimum subscription
1 200
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 1:1. One (1) existing share entitles one (1) unit right. One (1) unit right entitles the holder to subscribe for one (1) unit, consisting of one (1) share and one (1) free subscription option. Each warrant entitles the holder to subscribe for one (1) new share in the Company for SEK 3.50 (exercise price) during the period from January 10, 2020 to January 31, 2020. I
Type
Price
Pre-money valuation
Time
New issue
0.60 SEK
233M SEK
28 Jan - 15 Feb 2019
Share issue in ChromoGenics AB
Market
Nasdaq First North Sweden
Subscription period
28 Jan - 15 Feb 2019
Subscription price
0.60 SEK
Price per share
0.60 SEK
Target to raise
77 700 000 SEK
Types
Share issue
Pre-money valuation
233 000 000 SEK
Subscription block size
Minimum subscription
Record date
24 Jan 2019
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 1:3. Holdings of one (1) share entitle to three (3) subscription rights. One (1) subscription right entitles the holder to subscribe for one (1) new share.
Type
Price
Pre-money valuation
Time
New issue
0.50 SEK
86.38M SEK
25 Jun - 15 Jul 2019
Share issue in ChromoGenics AB
Market
Nasdaq First North Sweden
Subscription period
25 Jun - 15 Jul 2019
Subscription price
0.50 SEK
Price per share
0.50 SEK
Target to raise
86 377 990 SEK
Types
Share issue
Pre-money valuation
86 377 990 SEK
Subscription block size
Minimum subscription
Record date
21 Jun 2019
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 1:1. Holding of one (1) share gives one (1) subscription right. One (1) subscription right entitles the holder to subscribe for one (1) new share.
Type
Price
Pre-money valuation
Time
New issue
0.53 SEK
08 Jul 2019
Share issue in ChromoGenics AB
Market
Nasdaq First North Sweden
Subscription date
08 Jul 2019
Subscription price
Price per share
0.53 SEK
Target to raise
10 000 000 SEK
Types
Share issue
Pre-money valuation
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed to Wilhelm Risberg and Fredrik Lundgren.
Comments for offer & related information
Type
Price
Pre-money valuation
Time
New issue
0.56
11 Sep 2019
Share issue in ChromoGenics AB
Market
Nasdaq First North Sweden
Subscription date
11 Sep 2019
Subscription price
Price per share
0.56
Target to raise
15 470 000
Types
Share issue
Pre-money valuation
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Off-set issue directed to Hörmann-Verwertungen GmbH & Co. KG.
Comments for offer & related information
Type
Price
Pre-money valuation
Time
New issue
0.25 SEK
100.6M SEK
19 Feb - 04 Mar 2020
Share issue in ChromoGenics AB
Market
Nasdaq First North Sweden
Subscription period
19 Feb - 04 Mar 2020
Subscription price
0.25 SEK
Price per share
0.25 SEK
Target to raise
100 600 000 SEK
Types
Share issue
Pre-money valuation
100 600 000 SEK
Subscription block size
Minimum subscription
Record date
14 Feb 2020
Offer status
Active
Listing status
Listed
 
Issue terms
Each share held in the Company on the record date of February 14, 2020, will receive one (1) subscription right. One (1) subscription right entitles the owner to subscribe to one (1) new share.
Comments for offer & related information
The company shall issue a maximum of 402 380 447 shares.
The Rights Issue is guaranteed at 75.0 percent of the issue amount, corresponding to approximately SEK 75.4 million, through subscription and guarantee undertakings from existing shareholders and external investors.
Type
Ticker
ISIN
Market
OPTION
CHRO TO1
SE0009554470
Nasdaq First North Sweden
Sweden (SE)
Details of option in ChromoGenics AB with ticker CHRO TO1
Status
Archived
Order book id
Amount of instruments
13 921 312
Market cap
Currency
SEK
First trading date
Terms
Pre-emption 1:4. Four (4) existing warrants entitles the holder to subscribe for one (1) share.
Type
Price
Pre-money valuation
Time
Exercise
10.20 SEK
-
01 May - 31 May 2018
Option exercise terms for CHRO TO1
Market
Nasdaq First North Sweden
Exercise period(s)
01 May - 31 May 2018
Exercise price
10.20 SEK
Status
Closed
Issue terms
Pre-emption 1:4. Four (4) existing warrants entitles the holder to subscribe for one (1) share.
Type
Ticker
ISIN
Market
OPTION
CHRO TO2
SE0010662395
Nasdaq First North Sweden
Sweden (SE)
Details of option in ChromoGenics AB with ticker CHRO TO2
Status
Archived
Order book id
150385
Amount of instruments
18 974 669
Market cap
Currency
SEK
Segment
First North
Trading period
13 Feb 2018 - 29 Jan 2020
Terms
Update: Recalculated terms after share issue; One (1) warrant of series TO2 entitles the holder to subscribe for 2.02 new shares in the Company during the period 10 - 31 January 2020 for 1.74 SEK per share.

Update: Recalculated terms after share issue; One (1) warrant of series TO2 entitles the holder to subscribe for 1.62 new shares in the Company during the period 10 - 31 January 2020 for 2.17 SEK per share.

One (1) warrant of series TO2 entitles the holder to subscribe for one (1) new share in the Company during the period 10 - 31 January 2020 for 3.50 SEK per share.
Type
Price
Pre-money valuation
Time
Exercise
1.74 SEK
-
10 Jan - 31 Jan 2020
Option exercise terms for CHRO TO2
Former ticker
CHRO TO 2
Market
Nasdaq First North Sweden
Exercise period(s)
10 Jan - 31 Jan 2020
Exercise price
1.74 SEK
Status
Closed
Issue terms
Update: Recalculated terms after share issue; One (1) warrant of series TO2 entitles the holder to subscribe for 2.02 new shares in the Company during the period 10 - 31 January 2020 for 1.74 SEK per share.

Update: Recalculated terms after share issue; One (1) warrant of series TO2 entitles the holder to subscribe for 1.62 new shares in the Company during the period 10 - 31 January 2020 for 2.17 SEK per share.

One (1) warrant of series TO2 entitles the holder to subscribe for one (1) new share in the Company during the period 10 - 31 January 2020 for 3.50 SEK per share.
People
Number of Employees
36 people
Thomas Almesjö
CEO
Anders Brännström
Chairman of the board
Jerker Lundgren
Board member
Claes-Göran Granqvist
Board member
Anders Brännström
Board member
Poul Erik Schou-Pedersen
Board member
Company Details
Sector
MATERIALS, INDUSTRIALS

Address
Ullforsgatan 15
Zip code
752 28
City/district
Uppsala
Country
Sweden (SE)
Registration number
556630-1809
LEI code
549300ULKN252K60BG25
First trade date
23 Mar 2017
Registration date
05 Aug 2002
Short name
ChromoGenics

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date